HIV/AIDS Clinical Trials in Phoenix

Showing 421-440 of 518 trials

UNKNOWNPhase 4< 1 mile

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects

NCT00740064

To evaluate the efficacy and safety of Raltegravir and Epzicom over 48 weeks in ART-naive HIV-infected subjects.

HIV Infections

Denver Infectious Disease Consultants, PLLC30 participantsStarted May 2008

Phoenix, Arizona, United States • Denver, Colorado, United States • Santa Fe, New Mexico, United States

COMPLETEDPhase 2< 1 mile

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

NCT00298350

The purpose of this study is to evaluate the non-inferiority of ritonavir-boosted GS-9137 relative to a ritonavir-boosted Comparator Protease Inhibitor when used as part of combination antiretroviral regimens in subjects who have failed, or are failing, protease inhibitor therapy.

HIVHIV-1Human Immunodeficiency Virus

Gilead Sciences278 participantsStarted Feb 2006

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Beverly Hills, California, United States +51 more locations

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

HIV/AIDS Trials in Other Cities

Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients

Buprenorphine and Integrated HIV Care Evaluation

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection

A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

A Blood Test to Look at Cells of the Immune System in Healthy Children

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus

Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

Other Conditions in Phoenix